Skip to content

Estudios Clínicos

ECHO-NOVI Influencias ambientales en los resultados de salud infantil


Información del estudio

El programa Influencias ambientales en los resultados de salud infantil (ECHO) es una iniciativa de siete años de los Institutos Nacionales de Salud (NIH) para apoyar múltiples estudios de investigación que investigan los efectos de los factores ambientales en la salud y el desarrollo infantil. ECHO inscribirá a más de 50,000 niños en los Estados Unidos para recopilar una gran cantidad de datos que nos ayuden a desarrollar programas de salud, predecir el desarrollo de enfermedades y crear nuevas herramientas y enfoques para monitorear tanto el medio ambiente como a nuestros niños.

Neonatal Neurobehavior and Outcomes in Very Preterm Infants (NOVI) is the name of the study at Women & Infants Hospital. About 600 children from six NOVI study sites - including 111 infants from Women & Infants - will take part in ECHO. We are calling the combination of NOVI and ECHO “ECHO-NOVI.”

What is ECHO-NOVI? 

About one-third of infants born less than 30 weeks suffer long-term developmental challenges. We hope to identify which infants are more likely to become developmentally impaired and determine whether special types of care in the neonatal intensive care unit (NICU) and early developmental intervention services after discharge could improve the developmental outcomes for premature infants and their families. To date in the NOVI study, we have collected data on these infant’s early behavioral development up to the age of two. In ECHO-NOVI, we plan to follow these children through age seven to further determine potential mechanisms that lead to developmental and child health outcomes.

How will ECHO-NOVI work? 

ECHO-NOVI will be split into two phases. The first phase will follow the children who are now two through their developmental milestones at three and four years old. Phase II will follow them with annual study visits from five through seven years old. At this time, we are only asking for participation in phase I.

  • Study staff will interview the child’s mother or primary caregiver to discuss the child’s health, behavior and development, the family’s environment, and mom’s well-being since the child’s last NOVI visit.
  • Questionnaires will be completed to collect information on general health, behavior, the environment and development. The child will have developmental exams that look at his/her problem solving abilities, language and motor development. All assessments are conducted by experienced infant-toddler specialists.
  • We will collect biological samples from the child which include cheek cells, urine, hair, saliva, and toe nails. The cheek cell samples contain genetic information that instructs the body’s cells how to function. This will help researchers learn about how genes function and interact with other factors, and how children behave and respond to their environment.
  • All study information is kept confidential.

Contact Information

Interested in participating or want to learn more? 
Please call Erica at (401) 274-1122, ext. 48984 or email eoliveira@wihri.org. For assistance in Spanish, please call Brenda at (401) 274-1122, ext. 48945 or email brosarioperez@wihri.org.

Eligibility Criteria

How Can I Participate?

  • Para participar en el estudio ECHO-NOVI, el niño debe haber participado en el estudio NOVI en el Women & Infants Hospital.
  • Estamos reclutando niños NOVI en el estudio ECHO-NOVI a la edad de dos años. Si su hijo NOVI se perdió la ventana de dos años y desea participar en el estudio ECHO-NOVI, comuníquese con nosotros.

Compensación/Reembolso

Los participantes recibirán $100 al finalizar cada visita en la fase I por su tiempo y cooperación. El niño recibirá un pequeño obsequio de agradecimiento por su participación. Podemos ayudar con el transporte hacia y desde la visita si lo necesita.

Suscríbete a nuestro boletín de noticias

Nuestra Salud es una organización de emprendimiento social y 50% de las ganancias serán donadas a la Clinica Esperanza

We are a social venture company, donating 50% of profits to Clinica Esperanza/Hope Clinic